Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Assets Average (2017 - 2025)

Autolus Therapeutics' Assets Average history spans 9 years, with the latest figure at $625.5 million for Q4 2025.

  • For Q4 2025, Assets Average fell 22.31% year-over-year to $625.5 million; the TTM value through Dec 2025 reached $625.5 million, down 22.31%, while the annual FY2025 figure was $685.9 million, 18.45% up from the prior year.
  • Assets Average reached $625.5 million in Q4 2025 per AUTL's latest filing, down from $691.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $877.5 million in Q2 2024 to a low of $288.9 million in Q3 2022.
  • Average Assets Average over 5 years is $556.8 million, with a median of $475.1 million recorded in 2023.
  • Peak YoY movement for Assets Average: skyrocketed 106.05% in 2024, then decreased 22.31% in 2025.
  • A 5-year view of Assets Average shows it stood at $349.9 million in 2021, then rose by 7.76% to $377.1 million in 2022, then increased by 3.63% to $390.7 million in 2023, then soared by 106.05% to $805.1 million in 2024, then decreased by 22.31% to $625.5 million in 2025.
  • Per Business Quant, the three most recent readings for AUTL's Assets Average are $625.5 million (Q4 2025), $691.5 million (Q3 2025), and $733.7 million (Q2 2025).